ID   OPSD_BOVIN              Reviewed;         348 AA.
AC   P02699;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   07-APR-2021, entry version 209.
DE   RecName: Full=Rhodopsin;
GN   Name=RHO;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   PROTEIN SEQUENCE, RETINAL-BINDING SITE AT LYS-296, AND ACETYLATION AT
RP   MET-1.
RX   PubMed=6759163; DOI=10.1016/0014-5793(82)80805-3;
RA   Ovchinnikov Y.A.;
RT   "Rhodopsin and bacteriorhodopsin: structure-function relationships.";
RL   FEBS Lett. 148:179-191(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6194890; DOI=10.1016/0092-8674(83)90537-8;
RA   Nathans J., Hogness D.S.;
RT   "Isolation, sequence analysis, and intron-exon arrangement of the gene
RT   encoding bovine rhodopsin.";
RL   Cell 34:807-814(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-348.
RX   PubMed=2950966; DOI=10.1016/0169-328x(86)90031-8;
RA   Kuo C.-H., Yamagata K., Moyzis R.K., Bitensky M.W., Miki N.;
RT   "Multiple opsin mRNA species in bovine retina.";
RL   Brain Res. 387:251-260(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 205-348.
RX   PubMed=6228228; DOI=10.1016/0006-291x(83)90560-0;
RA   Koike S., Nabeshima Y., Ogata K., Fukui T., Ohtsuka E., Ikehara M.,
RA   Tokunaga F.;
RT   "Isolation and nucleotide sequence of a partial cDNA clone for bovine
RT   opsin.";
RL   Biochem. Biophys. Res. Commun. 116:563-567(1983).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=9541408; DOI=10.1002/pro.5560070325;
RA   Ball L.E., Oatis J.E. Jr., Dharmasiri K., Busman M., Wang J., Cowden L.B.,
RA   Galijatovic A., Chen N., Crouch R.K., Knapp D.R.;
RT   "Mass spectrometric analysis of integral membrane proteins: application to
RT   complete mapping of bacteriorhodopsins and rhodopsin.";
RL   Protein Sci. 7:758-764(1998).
RN   [6]
RP   GLYCOSYLATION AT ASN-2 AND ASN-15.
RX   PubMed=468821;
RA   Fukuda M.N., Papermaster D.S., Hargrave P.A.;
RT   "Rhodopsin carbohydrate. Structure of small oligosaccharides attached at
RT   two sites near the NH2 terminus.";
RL   J. Biol. Chem. 254:8201-8207(1979).
RN   [7]
RP   RETINAL-BINDING SITE, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=6870827; DOI=10.1042/bj2110045;
RA   Mullen E., Akhtar M.;
RT   "Structural studies on membrane-bound bovine rhodopsin.";
RL   Biochem. J. 211:45-54(1983).
RN   [8]
RP   PALMITOYLATION AT CYS-322 AND CYS-323, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=3350146; DOI=10.1016/0014-5793(88)80628-8;
RA   Ovchinnikov Y.A., Abdulaev N.G., Bogachuk A.S.;
RT   "Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of
RT   bovine rhodopsin are palmitylated.";
RL   FEBS Lett. 230:1-5(1988).
RN   [9]
RP   DISULFIDE BOND.
RX   PubMed=2145276;
RA   Karnik S.S., Khorana H.G.;
RT   "Assembly of functional rhodopsin requires a disulfide bond between
RT   cysteine residues 110 and 187.";
RL   J. Biol. Chem. 265:17520-17524(1990).
RN   [10]
RP   PHOSPHORYLATION AT SER-343, AND FUNCTION.
RX   PubMed=1396673; DOI=10.1111/j.1432-1033.1992.tb17232.x;
RA   Brown N.G., Fowles C., Sharma R., Akhtar M.;
RT   "Mechanistic studies on rhodopsin kinase. Light-dependent phosphorylation
RT   of C-terminal peptides of rhodopsin.";
RL   Eur. J. Biochem. 208:659-667(1992).
RN   [11]
RP   PALMITOYLATION AT CYS-322 AND CYS-323.
RX   PubMed=1512231;
RA   Papac D.I., Thornburg K.R., Buellesbach E.E., Crouch R.K., Knapp D.R.;
RT   "Palmitylation of a G-protein coupled receptor. Direct analysis by tandem
RT   mass spectrometry.";
RL   J. Biol. Chem. 267:16889-16894(1992).
RN   [12]
RP   MUTAGENESIS.
RX   PubMed=9405601; DOI=10.1073/pnas.94.26.14267;
RA   Cai K., Langen R., Hubbell W.L., Khorana H.G.;
RT   "Structure and function in rhodopsin: topology of the C-terminal
RT   polypeptide chain in relation to the cytoplasmic loops.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14267-14272(1997).
RN   [13]
RP   INTERACTION WITH RCVRN AND GRK1.
RX   PubMed=17020884; DOI=10.1074/jbc.m606913200;
RA   Ames J.B., Levay K., Wingard J.N., Lusin J.D., Slepak V.Z.;
RT   "Structural basis for calcium-induced inhibition of rhodopsin kinase by
RT   recoverin.";
RL   J. Biol. Chem. 281:37237-37245(2006).
RN   [14]
RP   SUBUNIT, INTERACTION WITH GNAT1, RETINAL-BINDING, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23303210; DOI=10.1096/fj.12-225383;
RA   Jastrzebska B., Orban T., Golczak M., Engel A., Palczewski K.;
RT   "Asymmetry of the rhodopsin dimer in complex with transducin.";
RL   FASEB J. 27:1572-1584(2013).
RN   [15]
RP   INTERACTION WITH SAG.
RX   PubMed=26200343; DOI=10.1038/nature14656;
RA   Kang Y., Zhou X.E., Gao X., He Y., Liu W., Ishchenko A., Barty A.,
RA   White T.A., Yefanov O., Han G.W., Xu Q., de Waal P.W., Ke J., Tan M.H.,
RA   Zhang C., Moeller A., West G.M., Pascal B.D., Van Eps N., Caro L.N.,
RA   Vishnivetskiy S.A., Lee R.J., Suino-Powell K.M., Gu X., Pal K., Ma J.,
RA   Zhi X., Boutet S., Williams G.J., Messerschmidt M., Gati C., Zatsepin N.A.,
RA   Wang D., James D., Basu S., Roy-Chowdhury S., Conrad C.E., Coe J., Liu H.,
RA   Lisova S., Kupitz C., Grotjohann I., Fromme R., Jiang Y., Tan M., Yang H.,
RA   Li J., Wang M., Zheng Z., Li D., Howe N., Zhao Y., Standfuss J.,
RA   Diederichs K., Dong Y., Potter C.S., Carragher B., Caffrey M., Jiang H.,
RA   Chapman H.N., Spence J.C., Fromme P., Weierstall U., Ernst O.P.,
RA   Katritch V., Gurevich V.V., Griffin P.R., Hubbell W.L., Stevens R.C.,
RA   Cherezov V., Melcher K., Xu H.E.;
RT   "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray
RT   laser.";
RL   Nature 523:561-567(2015).
RN   [16]
RP   INTERACTION WITH PRCD, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=27509380; DOI=10.1021/acs.biochem.6b00489;
RA   Spencer W.J., Pearring J.N., Salinas R.Y., Loiselle D.R., Skiba N.P.,
RA   Arshavsky V.Y.;
RT   "Progressive Rod-Cone Degeneration (PRCD) Protein Requires N-Terminal S-
RT   Acylation and Rhodopsin Binding for Photoreceptor Outer Segment
RT   Localization and Maintaining Intracellular Stability.";
RL   Biochemistry 55:5028-5037(2016).
RN   [17]
RP   SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=28655769; DOI=10.1074/jbc.m117.797100;
RA   Gao Y., Westfield G., Erickson J.W., Cerione R.A., Skiniotis G.,
RA   Ramachandran S.;
RT   "Isolation and structure-function characterization of a signaling-active
RT   rhodopsin-G protein complex.";
RL   J. Biol. Chem. 292:14280-14289(2017).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH ZINC ION AND
RP   ALL-TRANS-RETINAL, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION
RP   AT ASN-2 AND ASN-15, AND DISULFIDE BOND.
RX   PubMed=10926528; DOI=10.1126/science.289.5480.739;
RA   Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A.,
RA   Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M.;
RT   "Crystal structure of rhodopsin: a G protein-coupled receptor.";
RL   Science 289:739-745(2000).
RN   [19] {ECO:0007744|PDB:1HZX}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH RETINAL CHROMOPHORE
RP   AND ZINC ION, PALMITOYLATION AT CYS-322 AND CYS-323, TOPOLOGY,
RP   GLYCOSYLATION AT ASN-2 AND ASN-15, AND DISULFIDE BOND.
RX   PubMed=11425302; DOI=10.1021/bi0155091;
RA   Teller D.C., Okada T., Behnke C.A., Palczewski K., Stenkamp R.E.;
RT   "Advances in determination of a high-resolution three-dimensional structure
RT   of rhodopsin, a model of G-protein-coupled receptors (GPCRs).";
RL   Biochemistry 40:7761-7772(2001).
RN   [20]
RP   STRUCTURE BY NMR IN INACTIVATED AND ACTIVATED FORMS.
RX   PubMed=11570894; DOI=10.1021/bi015543f;
RA   Yeagle P.L., Choi G., Albert A.D.;
RT   "Studies on the structure of the G-protein-coupled receptor rhodopsin
RT   including the putative G-protein binding site in unactivated and activated
RT   forms.";
RL   Biochemistry 40:11932-11937(2001).
RN   [21]
RP   STRUCTURE BY NMR IN INACTIVATED AND ACTIVATED FORMS IN COMPLEX WITH
RP   ALL-TRANS-RETINAL, FUNCTION, TOPOLOGY, AND DISULFIDE BOND.
RX   PubMed=12044163; DOI=10.1021/bi025507w;
RA   Choi G., Landin J., Galan J.F., Birge R.R., Albert A.D., Yeagle P.L.;
RT   "Structural studies of metarhodopsin II, the activated form of the G-
RT   protein coupled receptor, rhodopsin.";
RL   Biochemistry 41:7318-7324(2002).
RN   [22] {ECO:0007744|PDB:1L9H}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH ZINC AND
RP   ALL-TRANS-RETINAL, TOPOLOGY, GLYCOSYLATION AT ASN-15, PALMITOYLATION AT
RP   CYS-322 AND CYS-323, AND DISULFIDE BONDS.
RX   PubMed=11972040; DOI=10.1073/pnas.082666399;
RA   Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., Shichida Y.;
RT   "Functional role of internal water molecules in rhodopsin revealed by X-ray
RT   crystallography.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5982-5987(2002).
RN   [23]
RP   STRUCTURE BY NMR OF 330-348 IN COMPLEX WITH SAG, AND PHOSPHORYLATION AT
RP   SER-334; THR-335; THR-336; SER-338; THR-340; THR-342 AND SER-343.
RX   PubMed=15111114; DOI=10.1016/s0014-5793(04)00226-1;
RA   Kisselev O.G., McDowell J.H., Hargrave P.A.;
RT   "The arrestin-bound conformation and dynamics of the phosphorylated
RT   carboxy-terminal region of rhodopsin.";
RL   FEBS Lett. 564:307-311(2004).
RN   [24] {ECO:0007744|PDB:1NZS}
RP   STRUCTURE BY NMR OF 330-348 IN COMPLEX WITH SAG, AND PHOSPHORYLATION AT
RP   SER-334; THR-335; THR-336; SER-338; THR-340; THR-342 AND SER-343.
RX   PubMed=15351781; DOI=10.1074/jbc.m407341200;
RA   Kisselev O.G., Downs M.A., McDowell J.H., Hargrave P.A.;
RT   "Conformational changes in the phosphorylated C-terminal domain of
RT   rhodopsin during rhodopsin arrestin interactions.";
RL   J. Biol. Chem. 279:51203-51207(2004).
RN   [25] {ECO:0007744|PDB:1U19}
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH ZINC AND
RP   ALL-TRANS-RETINAL, TOPOLOGY, PALMITOYLATION AT CYS-322 AND CYS-323,
RP   GLYCOSYLATION AT ASN-2 AND ASN-15, AND DISULFIDE BOND.
RX   PubMed=15327956; DOI=10.1016/j.jmb.2004.07.044;
RA   Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., Buss V.;
RT   "The retinal conformation and its environment in rhodopsin in light of a
RT   new 2.2 A crystal structure.";
RL   J. Mol. Biol. 342:571-583(2004).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) IN COMPLEX WITH ALL-TRANS-RETINAL,
RP   TOPOLOGY, GLYCOSYLATION AT ASN-2 AND ASN-15, AND DISULFIDE BONDS.
RX   PubMed=15491621; DOI=10.1016/j.jmb.2004.08.090;
RA   Li J., Edwards P.C., Burghammer M., Villa C., Schertler G.F.;
RT   "Structure of bovine rhodopsin in a trigonal crystal form.";
RL   J. Mol. Biol. 343:1409-1438(2004).
RN   [27]
RP   STRUCTURE BY NMR OF 231-252.
RX   PubMed=7578070; DOI=10.1021/bi00045a002;
RA   Yeagle P.L., Alderfer J.L., Albert A.D.;
RT   "Structure of the third cytoplasmic loop of bovine rhodopsin.";
RL   Biochemistry 34:14621-14625(1995).
RN   [28]
RP   STRUCTURE BY NMR OF 1-40; 93-123; 172-205 AND 268-293.
RX   PubMed=10888202; DOI=10.1034/j.1399-3011.2000.00707.x;
RA   Yeagle P.L., Salloum A., Chopra A., Bhawsar N., Ali L., Kuzmanovski G.,
RA   Alderfer J.L., Albert A.D.;
RT   "Structures of the intradiskal loops and amino terminus of the G-protein
RT   receptor, rhodopsin.";
RL   J. Pept. Res. 55:455-465(2000).
RN   [29]
RP   STRUCTURE BY NMR OF 291-315.
RX   PubMed=10930473;
RA   Yeagle P.L., Danis C., Choi G., Alderfer J.L., Albert A.D.;
RT   "Three dimensional structure of the seventh transmembrane helical domain of
RT   the G-protein receptor, rhodopsin.";
RL   Mol. Vis. 6:125-131(2000).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH RETINAL CHROMOPHORE,
RP   FUNCTION, AND TOPOLOGY.
RX   PubMed=16586416; DOI=10.1002/anie.200600595;
RA   Nakamichi H., Okada T.;
RT   "Crystallographic analysis of primary visual photochemistry.";
RL   Angew. Chem. Int. Ed. 45:4270-4273(2006).
RN   [31] {ECO:0007744|PDB:2HPY}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF INACTIVATED AND ACTIVATED FORMS
RP   IN COMPLEX WITH RETINAL CHROMOPHORE, FUNCTION, TOPOLOGY, PALMITOYLATION AT
RP   CYS-322 AND CYS-323, GLYCOSYLATION AT ASN-2 AND ASN-15, AND DISULFIDE
RP   BONDS.
RX   PubMed=16908857; DOI=10.1073/pnas.0601765103;
RA   Nakamichi H., Okada T.;
RT   "Local peptide movement in the photoreaction intermediate of rhodopsin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:12729-12734(2006).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (3.80 ANGSTROMS) INACTIVATED AND ACTIVATED FORMS,
RP   FUNCTION, AND TOPOLOGY.
RX   PubMed=17060607; DOI=10.1073/pnas.0608022103;
RA   Salom D., Lodowski D.T., Stenkamp R.E., Le Trong I., Golczak M.,
RA   Jastrzebska B., Harris T., Ballesteros J.A., Palczewski K.;
RT   "Crystal structure of a photoactivated deprotonated intermediate of
RT   rhodopsin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:16123-16128(2006).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) INACTIVATED AND ACTIVATED FORMS IN
RP   COMPLEX WITH RETINAL CHROMOPHORE, FUNCTION, AND TOPOLOGY.
RX   PubMed=17449675; DOI=10.1529/biophysj.107.108225;
RA   Nakamichi H., Buss V., Okada T.;
RT   "Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by
RT   x-ray crystallography.";
RL   Biophys. J. 92:L106-L108(2007).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 3-348, TOPOLOGY, AND MUTAGENESIS
RP   OF ASN-2; ASN-15 AND ASP-282.
RX   PubMed=17825322; DOI=10.1016/j.jmb.2007.03.007;
RA   Standfuss J., Xie G., Edwards P.C., Burghammer M., Oprian D.D.,
RA   Schertler G.F.;
RT   "Crystal structure of a thermally stable rhodopsin mutant.";
RL   J. Mol. Biol. 372:1179-1188(2007).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS), AND TOPOLOGY.
RX   PubMed=18645239; DOI=10.1107/s0907444908017162;
RA   Stenkamp R.E.;
RT   "Alternative models for two crystal structures of bovine rhodopsin.";
RL   Acta Crystallogr. D 64:902-904(2008).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS), DIMERIZATION, SUBUNIT, AND
RP   TOPOLOGY.
RX   PubMed=18563085; DOI=10.1038/nature07063;
RA   Park J.H., Scheerer P., Hofmann K.P., Choe H.-W., Ernst O.P.;
RT   "Crystal structure of the ligand-free G-protein-coupled receptor opsin.";
RL   Nature 454:183-187(2008).
RN   [37] {ECO:0007744|PDB:3DQB}
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) IN COMPLEX WITH GNAT1, FUNCTION,
RP   ACTIVATION MECHANISM, TOPOLOGY, GLYCOSYLATION AT ASN-2 AND ASN-15,
RP   PALMITOYLATION AT CYS-322 AND CYS-323, AND DISULFIDE BONDS.
RX   PubMed=18818650; DOI=10.1038/nature07330;
RA   Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.-W.,
RA   Hofmann K.P., Ernst O.P.;
RT   "Crystal structure of opsin in its G-protein-interacting conformation.";
RL   Nature 455:497-502(2008).
RN   [38] {ECO:0007744|PDB:2X72}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF MUTANT GLN-113 IN COMPLEX WITH
RP   GNAT1, FUNCTION, GLYCOSYLATION AT ASN-15, DISULFIDE BONDS, AND MUTAGENESIS
RP   OF GLU-113.
RX   PubMed=21389983; DOI=10.1038/nature09795;
RA   Standfuss J., Edwards P.C., D'Antona A., Fransen M., Xie G., Oprian D.D.,
RA   Schertler G.F.;
RT   "The structural basis of agonist-induced activation in constitutively
RT   active rhodopsin.";
RL   Nature 471:656-660(2011).
RN   [39] {ECO:0007744|PDB:4A4M}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF MUTANT TYR-257 IN COMPLEX WITH
RP   ALL-TRANS-RETINAL AND GNAT3, FUNCTION, PALMITOYLATION AT CYS-323,
RP   GLYCOSYLATION AT ASN-15, DISULFIDE BOND, AND MUTAGENESIS OF MET-257.
RX   PubMed=22198838; DOI=10.1073/pnas.1114089108;
RA   Deupi X., Edwards P., Singhal A., Nickle B., Oprian D., Schertler G.,
RA   Standfuss J.;
RT   "Stabilized G protein binding site in the structure of constitutively
RT   active metarhodopsin-II.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:119-124(2012).
RN   [40] {ECO:0007744|PDB:4BEY, ECO:0007744|PDB:4BEZ}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF MUTANT ASP-90 IN COMPLEX WITH
RP   GNAT1, INTERACTION WITH GNAT1 AND SAG, TOPOLOGY, GLYCOSYLATION AT ASN-15,
RP   PALMITOYLATION AT CYS-323, DISULFIDE BONDS, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND MUTAGENESIS OF GLY-90.
RX   PubMed=23579341; DOI=10.1038/embor.2013.44;
RA   Singhal A., Ostermaier M.K., Vishnivetskiy S.A., Panneels V., Homan K.T.,
RA   Tesmer J.J., Veprintsev D., Deupi X., Gurevich V.V., Schertler G.F.,
RA   Standfuss J.;
RT   "Insights into congenital stationary night blindness based on the structure
RT   of G90D rhodopsin.";
RL   EMBO Rep. 14:520-526(2013).
RN   [41] {ECO:0007744|PDB:4PXF}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH SAG PEPTIDE,
RP   FUNCTION, INTERACTION WITH SAG AND GNAT1, TOPOLOGY, GLYCOSYLATION AT
RP   ASN-15, AND DISULFIDE BONDS.
RX   PubMed=25205354; DOI=10.1038/ncomms5801;
RA   Szczepek M., Beyriere F., Hofmann K.P., Elgeti M., Kazmin R., Rose A.,
RA   Bartl F.J., von Stetten D., Heck M., Sommer M.E., Hildebrand P.W.,
RA   Scheerer P.;
RT   "Crystal structure of a common GPCR-binding interface for G protein and
RT   arrestin.";
RL   Nat. Commun. 5:4801-4801(2014).
RN   [42] {ECO:0007744|PDB:4X1H}
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) IN COMPLEX WITH GNAT1 PEPTIDE,
RP   TOPOLOGY, GLYCOSYLATION AT ASN-2 AND ASN-15, PALMITOYLATION AT CYS-322 AND
RP   CYS-323, AND DISULFIDE BOND.
RX   PubMed=26526852; DOI=10.1016/j.str.2015.09.015;
RA   Blankenship E., Vahedi-Faridi A., Lodowski D.T.;
RT   "The High-Resolution Structure of Activated Opsin Reveals a Conserved
RT   Solvent Network in the Transmembrane Region Essential for Activation.";
RL   Structure 23:2358-2364(2015).
RN   [43] {ECO:0007744|PDB:5DYS, ECO:0007744|PDB:5EN0}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF MUTANT ILE-94 IN COMPLEX WITH
RP   ALL-TRANS-RETINAL AND GNAT3, FUNCTION, TOPOLOGY, GLYCOSYLATION AT ASN-15,
RP   PALMITOYLATION AT CYS-322 AND CYS-323, DISULFIDE BONDS, AND MUTAGENESIS OF
RP   THR-94.
RX   PubMed=27458239; DOI=10.15252/embr.201642671;
RA   Singhal A., Guo Y., Matkovic M., Schertler G., Deupi X., Yan E.C.,
RA   Standfuss J.;
RT   "Structural role of the T94I rhodopsin mutation in congenital stationary
RT   night blindness.";
RL   EMBO Rep. 17:1431-1440(2016).
CC   -!- FUNCTION: Photoreceptor required for image-forming vision at low light
CC       intensity. Required for photoreceptor cell viability after birth (By
CC       similarity). Light-induced isomerization of 11-cis to all-trans retinal
CC       triggers a conformational change that activates signaling via G-
CC       proteins (PubMed:10926528, PubMed:12044163, PubMed:11972040,
CC       PubMed:16908857, PubMed:16586416, PubMed:17060607, PubMed:17449675,
CC       PubMed:18818650, PubMed:21389983, PubMed:22198838, PubMed:23579341,
CC       PubMed:25205354, PubMed:27458239). Subsequent receptor phosphorylation
CC       mediates displacement of the bound G-protein alpha subunit by the
CC       arrestin SAG and terminates signaling (PubMed:1396673,
CC       PubMed:15111114). {ECO:0000250|UniProtKB:P08100,
CC       ECO:0000269|PubMed:1396673, ECO:0000269|PubMed:16586416,
CC       ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
CC       ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:18818650,
CC       ECO:0000269|PubMed:21389983, ECO:0000269|PubMed:22198838,
CC       ECO:0000269|PubMed:23579341, ECO:0000269|PubMed:25205354,
CC       ECO:0000269|PubMed:27458239, ECO:0000305|PubMed:10926528,
CC       ECO:0000305|PubMed:11972040, ECO:0000305|PubMed:12044163,
CC       ECO:0000305|PubMed:15111114, ECO:0000305|PubMed:26526852}.
CC   -!- SUBUNIT: Homodimer (PubMed:23303210, PubMed:18563085). May form a
CC       complex composed of RHO, GRK1 and RCVRN in a Ca(2+)-dependent manner;
CC       RCVRN prevents the interaction between GRK1 and RHO (PubMed:17020884).
CC       Interacts with GRK1 (By similarity). Interacts (phosphorylated form)
CC       with SAG (PubMed:26200343, PubMed:15111114, PubMed:15351781,
CC       PubMed:23579341, PubMed:25205354). Interacts with GNAT1
CC       (PubMed:23303210, PubMed:28655769, PubMed:18818650, PubMed:21389983,
CC       PubMed:23579341, PubMed:26526852). Interacts with GNAT3
CC       (PubMed:22198838, PubMed:27458239). SAG and G-proteins compete for a
CC       common binding site (By similarity). Interacts with PRCD; the
CC       interaction promotes PRCD stability (PubMed:27509380).
CC       {ECO:0000250|UniProtKB:P08100, ECO:0000269|PubMed:11425302,
CC       ECO:0000269|PubMed:15111114, ECO:0000269|PubMed:15351781,
CC       ECO:0000269|PubMed:16586416, ECO:0000269|PubMed:17020884,
CC       ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:18563085,
CC       ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
CC       ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23303210,
CC       ECO:0000269|PubMed:23579341, ECO:0000269|PubMed:25205354,
CC       ECO:0000269|PubMed:26200343, ECO:0000269|PubMed:26526852,
CC       ECO:0000269|PubMed:27458239, ECO:0000269|PubMed:27509380,
CC       ECO:0000269|PubMed:28655769}.
CC   -!- INTERACTION:
CC       P02699; P04695: GNAT1; NbExp=3; IntAct=EBI-8592832, EBI-7052221;
CC       P02699; P02699: RHO; NbExp=6; IntAct=EBI-8592832, EBI-8592832;
CC       P02699; P08168-1: SAG; NbExp=23; IntAct=EBI-8592832, EBI-15575296;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10926528,
CC       ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23303210,
CC       ECO:0000269|PubMed:27509380, ECO:0000269|PubMed:3350146,
CC       ECO:0000269|PubMed:9541408}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10926528, ECO:0000269|PubMed:11425302,
CC       ECO:0000269|PubMed:11972040, ECO:0000269|PubMed:15327956,
CC       ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
CC       ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
CC       ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
CC       ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
CC       ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
CC       ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
CC       ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
CC       ECO:0000269|PubMed:27458239}. Cell projection, cilium, photoreceptor
CC       outer segment {ECO:0000269|PubMed:27509380,
CC       ECO:0000269|PubMed:28655769, ECO:0000269|PubMed:3350146,
CC       ECO:0000269|PubMed:9541408}. Note=Synthesized in the inner segment (IS)
CC       of rod photoreceptor cells before vectorial transport to disk membranes
CC       in the rod outer segment (OS) photosensory cilia.
CC       {ECO:0000250|UniProtKB:P08100}.
CC   -!- TISSUE SPECIFICITY: Expressed in rod-shaped photoreceptor cells in the
CC       retina that mediate vision in dim light (at protein level).
CC       {ECO:0000269|PubMed:23303210, ECO:0000269|PubMed:28655769,
CC       ECO:0000269|PubMed:3350146, ECO:0000269|PubMed:9541408}.
CC   -!- PTM: Phosphorylated on some or all of the serine and threonine residues
CC       present in the C-terminal region. {ECO:0000269|PubMed:1396673,
CC       ECO:0000269|PubMed:15111114, ECO:0000269|PubMed:15351781}.
CC   -!- PTM: Contains one covalently linked retinal chromophore. Upon light
CC       absorption, the covalently bound 11-cis-retinal is converted to all-
CC       trans-retinal. After hydrolysis of the Schiff base and release of the
CC       covalently bound all-trans-retinal, active rhodopsin is regenerated by
CC       binding of a fresh molecule of 11-cis-retinal.
CC       {ECO:0000269|PubMed:10926528, ECO:0000269|PubMed:11425302,
CC       ECO:0000269|PubMed:11972040, ECO:0000269|PubMed:12044163,
CC       ECO:0000269|PubMed:15327956, ECO:0000269|PubMed:15491621,
CC       ECO:0000269|PubMed:16586416, ECO:0000269|PubMed:16908857,
CC       ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:21389983,
CC       ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23303210,
CC       ECO:0000269|PubMed:27458239, ECO:0000269|PubMed:6870827,
CC       ECO:0000305|PubMed:6759163}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. Opsin
CC       subfamily. {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; K00506; AAA30674.1; -; Genomic_DNA.
DR   EMBL; K00502; AAA30674.1; JOINED; Genomic_DNA.
DR   EMBL; K00503; AAA30674.1; JOINED; Genomic_DNA.
DR   EMBL; K00504; AAA30674.1; JOINED; Genomic_DNA.
DR   EMBL; K00505; AAA30674.1; JOINED; Genomic_DNA.
DR   EMBL; M21606; AAA30675.1; -; mRNA.
DR   PIR; A90840; OOBO.
DR   RefSeq; NP_001014890.1; NM_001014890.2.
DR   PDB; 1BOJ; Model; -; A=1-348.
DR   PDB; 1BOK; Model; -; A=1-348.
DR   PDB; 1EDS; NMR; -; A=93-123.
DR   PDB; 1EDV; NMR; -; A=172-205.
DR   PDB; 1EDW; NMR; -; A=268-293.
DR   PDB; 1EDX; NMR; -; A=1-40.
DR   PDB; 1F88; X-ray; 2.80 A; A/B=1-348.
DR   PDB; 1FDF; NMR; -; A=291-315.
DR   PDB; 1GZM; X-ray; 2.65 A; A/B=1-348.
DR   PDB; 1HZX; X-ray; 2.80 A; A/B=1-348.
DR   PDB; 1JFP; NMR; -; A=1-348.
DR   PDB; 1L9H; X-ray; 2.60 A; A/B=1-348.
DR   PDB; 1LN6; NMR; -; A=1-348.
DR   PDB; 1N3M; Model; -; A/B/C/D/E/F=1-348.
DR   PDB; 1NZS; NMR; -; A=330-348.
DR   PDB; 1OV0; Model; -; A=1-348.
DR   PDB; 1OV1; Model; -; A=1-348.
DR   PDB; 1U19; X-ray; 2.20 A; A/B=1-348.
DR   PDB; 1VQX; NMR; -; A=330-348.
DR   PDB; 2G87; X-ray; 2.60 A; A/B=1-348.
DR   PDB; 2HPY; X-ray; 2.80 A; A/B=1-348.
DR   PDB; 2I35; X-ray; 3.80 A; A=1-348.
DR   PDB; 2I36; X-ray; 4.10 A; A/B/C=1-348.
DR   PDB; 2I37; X-ray; 4.15 A; A/B/C=1-348.
DR   PDB; 2IQK; Model; -; A=1-348.
DR   PDB; 2J4Y; X-ray; 3.40 A; A/B=1-348.
DR   PDB; 2PED; X-ray; 2.95 A; A/B=1-348.
DR   PDB; 2X72; X-ray; 3.00 A; A=1-348.
DR   PDB; 3C9L; X-ray; 2.65 A; A=1-348.
DR   PDB; 3C9M; X-ray; 3.40 A; A=1-348.
DR   PDB; 3CAP; X-ray; 2.90 A; A/B=1-348.
DR   PDB; 3DQB; X-ray; 3.20 A; A=1-348.
DR   PDB; 3OAX; X-ray; 2.60 A; A/B=1-348.
DR   PDB; 3PQR; X-ray; 2.85 A; A=1-348.
DR   PDB; 3PXO; X-ray; 3.00 A; A=1-348.
DR   PDB; 4A4M; X-ray; 3.30 A; A=1-348.
DR   PDB; 4BEY; X-ray; 2.90 A; A=1-348.
DR   PDB; 4BEZ; X-ray; 3.30 A; A=1-348.
DR   PDB; 4J4Q; X-ray; 2.65 A; A=1-348.
DR   PDB; 4PXF; X-ray; 2.75 A; A=1-348.
DR   PDB; 4X1H; X-ray; 2.29 A; A=1-348.
DR   PDB; 5DYS; X-ray; 2.30 A; A=1-348.
DR   PDB; 5EN0; X-ray; 2.81 A; A=1-348.
DR   PDB; 5TE3; X-ray; 2.70 A; A=1-348.
DR   PDB; 5TE5; X-ray; 4.01 A; A=1-348.
DR   PDB; 5WKT; X-ray; 3.20 A; A=1-348.
DR   PDB; 6FK6; X-ray; 2.36 A; A=1-326.
DR   PDB; 6FK7; X-ray; 2.62 A; A=1-348.
DR   PDB; 6FK8; X-ray; 2.87 A; A=1-348.
DR   PDB; 6FK9; X-ray; 2.63 A; A=1-348.
DR   PDB; 6FKA; X-ray; 2.70 A; A=1-348.
DR   PDB; 6FKB; X-ray; 3.03 A; A=1-328.
DR   PDB; 6FKC; X-ray; 2.46 A; A=1-348.
DR   PDB; 6FKD; X-ray; 2.49 A; A=1-348.
DR   PDB; 6FUF; X-ray; 3.12 A; A=2-317.
DR   PDB; 6NWE; X-ray; 2.71 A; A=1-348.
DR   PDB; 6OFJ; EM; 4.50 A; A/B=1-348.
DR   PDB; 6OY9; EM; 3.90 A; R=1-348.
DR   PDB; 6OYA; EM; 3.30 A; R=1-348.
DR   PDB; 6PEL; X-ray; 3.19 A; A=1-348.
DR   PDB; 6PGS; X-ray; 2.90 A; A=1-348.
DR   PDB; 6PH7; X-ray; 2.90 A; A=1-348.
DR   PDB; 6QNO; EM; 4.38 A; R=1-348.
DR   PDBsum; 1BOJ; -.
DR   PDBsum; 1BOK; -.
DR   PDBsum; 1EDS; -.
DR   PDBsum; 1EDV; -.
DR   PDBsum; 1EDW; -.
DR   PDBsum; 1EDX; -.
DR   PDBsum; 1F88; -.
DR   PDBsum; 1FDF; -.
DR   PDBsum; 1GZM; -.
DR   PDBsum; 1HZX; -.
DR   PDBsum; 1JFP; -.
DR   PDBsum; 1L9H; -.
DR   PDBsum; 1LN6; -.
DR   PDBsum; 1N3M; -.
DR   PDBsum; 1NZS; -.
DR   PDBsum; 1OV0; -.
DR   PDBsum; 1OV1; -.
DR   PDBsum; 1U19; -.
DR   PDBsum; 1VQX; -.
DR   PDBsum; 2G87; -.
DR   PDBsum; 2HPY; -.
DR   PDBsum; 2I35; -.
DR   PDBsum; 2I36; -.
DR   PDBsum; 2I37; -.
DR   PDBsum; 2IQK; -.
DR   PDBsum; 2J4Y; -.
DR   PDBsum; 2PED; -.
DR   PDBsum; 2X72; -.
DR   PDBsum; 3C9L; -.
DR   PDBsum; 3C9M; -.
DR   PDBsum; 3CAP; -.
DR   PDBsum; 3DQB; -.
DR   PDBsum; 3OAX; -.
DR   PDBsum; 3PQR; -.
DR   PDBsum; 3PXO; -.
DR   PDBsum; 4A4M; -.
DR   PDBsum; 4BEY; -.
DR   PDBsum; 4BEZ; -.
DR   PDBsum; 4J4Q; -.
DR   PDBsum; 4PXF; -.
DR   PDBsum; 4X1H; -.
DR   PDBsum; 5DYS; -.
DR   PDBsum; 5EN0; -.
DR   PDBsum; 5TE3; -.
DR   PDBsum; 5TE5; -.
DR   PDBsum; 5WKT; -.
DR   PDBsum; 6FK6; -.
DR   PDBsum; 6FK7; -.
DR   PDBsum; 6FK8; -.
DR   PDBsum; 6FK9; -.
DR   PDBsum; 6FKA; -.
DR   PDBsum; 6FKB; -.
DR   PDBsum; 6FKC; -.
DR   PDBsum; 6FKD; -.
DR   PDBsum; 6FUF; -.
DR   PDBsum; 6NWE; -.
DR   PDBsum; 6OFJ; -.
DR   PDBsum; 6OY9; -.
DR   PDBsum; 6OYA; -.
DR   PDBsum; 6PEL; -.
DR   PDBsum; 6PGS; -.
DR   PDBsum; 6PH7; -.
DR   PDBsum; 6QNO; -.
DR   BMRB; P02699; -.
DR   SMR; P02699; -.
DR   BioGRID; 166570; 2.
DR   DIP; DIP-29225N; -.
DR   ELM; P02699; -.
DR   IntAct; P02699; 5.
DR   MINT; P02699; -.
DR   STRING; 9913.ENSBTAP00000001730; -.
DR   BindingDB; P02699; -.
DR   ChEMBL; CHEMBL5739; -.
DR   TCDB; 9.A.14.1.17; the g-protein-coupled receptor (gpcr) family.
DR   GlyConnect; 523; 4 N-Linked glycans.
DR   iPTMnet; P02699; -.
DR   SwissPalm; P02699; -.
DR   PaxDb; P02699; -.
DR   ABCD; P02699; 1 sequenced antibody.
DR   Ensembl; ENSBTAT00000001730; ENSBTAP00000001730; ENSBTAG00000001310.
DR   GeneID; 509933; -.
DR   KEGG; bta:509933; -.
DR   CTD; 6010; -.
DR   VGNC; VGNC:33942; RHO.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230491; -.
DR   HOGENOM; CLU_009579_3_0_1; -.
DR   InParanoid; P02699; -.
DR   OMA; QYYLVNP; -.
DR   OrthoDB; 940057at2759; -.
DR   TreeFam; TF324998; -.
DR   Reactome; R-BTA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   Reactome; R-BTA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-BTA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-BTA-418594; G alpha (i) signalling events.
DR   Reactome; R-BTA-419771; Opsins.
DR   Reactome; R-BTA-5620916; VxPx cargo-targeting to cilium.
DR   EvolutionaryTrace; P02699; -.
DR   PRO; PR:P02699; -.
DR   Proteomes; UP000009136; Chromosome 22.
DR   Bgee; ENSBTAG00000001310; Expressed in testis and 2 other tissues.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0097648; C:G protein-coupled receptor complex; IDA:CAFA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:AgBase.
DR   GO; GO:0019867; C:outer membrane; IDA:CAFA.
DR   GO; GO:0097381; C:photoreceptor disc membrane; ISS:UniProtKB.
DR   GO; GO:0060342; C:photoreceptor inner segment membrane; ISS:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; IBA:GO_Central.
DR   GO; GO:0042622; C:photoreceptor outer segment membrane; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0097225; C:sperm midpiece; IEA:Ensembl.
DR   GO; GO:0005502; F:11-cis retinal binding; IDA:UniProtKB.
DR   GO; GO:1990763; F:arrestin family protein binding; IPI:CAFA.
DR   GO; GO:0008020; F:G protein-coupled photoreceptor activity; IDA:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:CAFA.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0002046; F:opsin binding; IDA:CAFA.
DR   GO; GO:0008270; F:zinc ion binding; IDA:CAFA.
DR   GO; GO:0016038; P:absorption of visible light; IDA:UniProtKB.
DR   GO; GO:0071482; P:cellular response to light stimulus; IBA:GO_Central.
DR   GO; GO:0050960; P:detection of temperature stimulus involved in thermoception; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl.
DR   GO; GO:0007602; P:phototransduction; IBA:GO_Central.
DR   GO; GO:0007603; P:phototransduction, visible light; IDA:AgBase.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW.
DR   GO; GO:0009416; P:response to light stimulus; IDA:CAFA.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043052; P:thermotaxis; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   DisProt; DP00271; -.
DR   IDEAL; IID50247; -.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001760; Opsin.
DR   InterPro; IPR027430; Retinal_BS.
DR   InterPro; IPR000732; Rhodopsin.
DR   InterPro; IPR019477; Rhodopsin_N.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF10413; Rhodopsin_N; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00238; OPSIN.
DR   PRINTS; PR00579; RHODOPSIN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
DR   PROSITE; PS00238; OPSIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell projection; Chromophore;
KW   Direct protein sequencing; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Metal-binding; Palmitate;
KW   Phosphoprotein; Photoreceptor protein; Receptor; Reference proteome;
KW   Retinal protein; Sensory transduction; Transducer; Transmembrane;
KW   Transmembrane helix; Vision; Zinc.
FT   CHAIN           1..348
FT                   /note="Rhodopsin"
FT                   /id="PRO_0000197653"
FT   TOPO_DOM        1..36
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        37..61
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        62..73
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        74..96
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        97..110
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        111..133
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        134..152
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        153..173
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        174..202
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        203..224
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        225..252
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        253..274
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        275..286
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TRANSMEM        287..308
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   TOPO_DOM        309..348
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17060607,
FT                   ECO:0000269|PubMed:17449675, ECO:0000269|PubMed:17825322,
FT                   ECO:0000269|PubMed:18563085, ECO:0000269|PubMed:18645239,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239"
FT   REGION          330..348
FT                   /note="Interaction with SAG"
FT                   /evidence="ECO:0000269|PubMed:15111114"
FT   MOTIF           134..136
FT                   /note="'Ionic lock' involved in activated form
FT                   stabilization"
FT                   /evidence="ECO:0000305|PubMed:21389983,
FT                   ECO:0000305|PubMed:22198838, ECO:0000305|PubMed:26526852,
FT                   ECO:0000305|PubMed:27458239"
FT   METAL           201
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0007744|PDB:1F88,
FT                   ECO:0007744|PDB:1HZX"
FT   METAL           279
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0007744|PDB:1F88,
FT                   ECO:0007744|PDB:1HZX"
FT   SITE            113
FT                   /note="Plays an important role in the conformation switch
FT                   to the active conformation"
FT                   /evidence="ECO:0000269|PubMed:21389983,
FT                   ECO:0000305|PubMed:22198838, ECO:0000305|PubMed:23579341,
FT                   ECO:0000305|PubMed:27458239"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000305|PubMed:6759163"
FT   MOD_RES         296
FT                   /note="N6-(retinylidene)lysine"
FT                   /evidence="ECO:0000269|PubMed:10926528,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16586416,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:17449675,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23303210,
FT                   ECO:0000269|PubMed:27458239, ECO:0000269|PubMed:6870827,
FT                   ECO:0000305|PubMed:6759163, ECO:0007744|PDB:1F88,
FT                   ECO:0007744|PDB:1GZM, ECO:0007744|PDB:1HZX,
FT                   ECO:0007744|PDB:1JFP, ECO:0007744|PDB:2HPY,
FT                   ECO:0007744|PDB:3C9L, ECO:0007744|PDB:3OAX,
FT                   ECO:0007744|PDB:3PQR, ECO:0007744|PDB:3PXO,
FT                   ECO:0007744|PDB:5DYS"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         335
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         340
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         342
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:15111114,
FT                   ECO:0000269|PubMed:15351781"
FT   MOD_RES         343
FT                   /note="Phosphoserine; by RK and GRK7"
FT                   /evidence="ECO:0000269|PubMed:1396673,
FT                   ECO:0000269|PubMed:15111114, ECO:0000269|PubMed:15351781"
FT   LIPID           322
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:11425302,
FT                   ECO:0000269|PubMed:11972040, ECO:0000269|PubMed:1512231,
FT                   ECO:0000269|PubMed:15327956, ECO:0000269|PubMed:16908857,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239, ECO:0000269|PubMed:3350146,
FT                   ECO:0007744|PDB:1HZX, ECO:0007744|PDB:1L9H,
FT                   ECO:0007744|PDB:2HPY, ECO:0007744|PDB:4X1H,
FT                   ECO:0007744|PDB:5DYS"
FT   LIPID           323
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:11425302,
FT                   ECO:0000269|PubMed:11972040, ECO:0000269|PubMed:1512231,
FT                   ECO:0000269|PubMed:15327956, ECO:0000269|PubMed:16908857,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:27458239, ECO:0000269|PubMed:3350146,
FT                   ECO:0007744|PDB:1HZX, ECO:0007744|PDB:1L9H,
FT                   ECO:0007744|PDB:2HPY, ECO:0007744|PDB:4BEY,
FT                   ECO:0007744|PDB:4PXF, ECO:0007744|PDB:4X1H,
FT                   ECO:0007744|PDB:5DYS"
FT   CARBOHYD        2
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11425302,
FT                   ECO:0000269|PubMed:15327956, ECO:0000269|PubMed:15491621,
FT                   ECO:0000269|PubMed:16908857, ECO:0000269|PubMed:18818650,
FT                   ECO:0000269|PubMed:26526852, ECO:0000269|PubMed:468821,
FT                   ECO:0000269|PubMed:6759163, ECO:0007744|PDB:1F88,
FT                   ECO:0007744|PDB:1GZM, ECO:0007744|PDB:1HZX,
FT                   ECO:0007744|PDB:1U19, ECO:0007744|PDB:2G87,
FT                   ECO:0007744|PDB:2HPY, ECO:0007744|PDB:2I35,
FT                   ECO:0007744|PDB:2I36, ECO:0007744|PDB:2I37,
FT                   ECO:0007744|PDB:2PED, ECO:0007744|PDB:3C9L,
FT                   ECO:0007744|PDB:3CAP, ECO:0007744|PDB:3DQB,
FT                   ECO:0007744|PDB:3OAX, ECO:0007744|PDB:3PQR,
FT                   ECO:0007744|PDB:3PXO, ECO:0007744|PDB:4X1H"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11425302,
FT                   ECO:0000269|PubMed:11972040, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16908857,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:22198838, ECO:0000269|PubMed:23579341,
FT                   ECO:0000269|PubMed:25205354, ECO:0000269|PubMed:26526852,
FT                   ECO:0000269|PubMed:468821, ECO:0000269|PubMed:6759163,
FT                   ECO:0007744|PDB:1F88, ECO:0007744|PDB:1GZM,
FT                   ECO:0007744|PDB:1HZX, ECO:0007744|PDB:1L9H,
FT                   ECO:0007744|PDB:1U19, ECO:0007744|PDB:2G87,
FT                   ECO:0007744|PDB:2HPY, ECO:0007744|PDB:2I35,
FT                   ECO:0007744|PDB:2I36, ECO:0007744|PDB:2I37,
FT                   ECO:0007744|PDB:2J4Y, ECO:0007744|PDB:2PED,
FT                   ECO:0007744|PDB:2X72, ECO:0007744|PDB:3C9L,
FT                   ECO:0007744|PDB:3C9M, ECO:0007744|PDB:3CAP,
FT                   ECO:0007744|PDB:3DQB, ECO:0007744|PDB:3OAX,
FT                   ECO:0007744|PDB:3PQR, ECO:0007744|PDB:3PXO,
FT                   ECO:0007744|PDB:4A4M, ECO:0007744|PDB:4BEY,
FT                   ECO:0007744|PDB:4BEZ, ECO:0007744|PDB:4J4Q,
FT                   ECO:0007744|PDB:4PXF, ECO:0007744|PDB:4X1H,
FT                   ECO:0007744|PDB:5DYS, ECO:0007744|PDB:5EN0,
FT                   ECO:0007744|PDB:5TE3"
FT   DISULFID        110..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:11425302, ECO:0000269|PubMed:11972040,
FT                   ECO:0000269|PubMed:12044163, ECO:0000269|PubMed:15327956,
FT                   ECO:0000269|PubMed:15491621, ECO:0000269|PubMed:16908857,
FT                   ECO:0000269|PubMed:18818650, ECO:0000269|PubMed:21389983,
FT                   ECO:0000269|PubMed:2145276, ECO:0000269|PubMed:22198838,
FT                   ECO:0000269|PubMed:23579341, ECO:0000269|PubMed:26526852,
FT                   ECO:0007744|PDB:1F88, ECO:0007744|PDB:1GZM,
FT                   ECO:0007744|PDB:1HZX, ECO:0007744|PDB:1JFP,
FT                   ECO:0007744|PDB:1L9H, ECO:0007744|PDB:1LN6,
FT                   ECO:0007744|PDB:1U19, ECO:0007744|PDB:2G87,
FT                   ECO:0007744|PDB:2HPY, ECO:0007744|PDB:2I35,
FT                   ECO:0007744|PDB:2I36, ECO:0007744|PDB:2I37,
FT                   ECO:0007744|PDB:2J4Y, ECO:0007744|PDB:2PED,
FT                   ECO:0007744|PDB:2X72, ECO:0007744|PDB:3C9L,
FT                   ECO:0007744|PDB:3C9M, ECO:0007744|PDB:3CAP,
FT                   ECO:0007744|PDB:3DQB, ECO:0007744|PDB:3OAX,
FT                   ECO:0007744|PDB:3PQR, ECO:0007744|PDB:3PXO,
FT                   ECO:0007744|PDB:4A4M, ECO:0007744|PDB:4BEY,
FT                   ECO:0007744|PDB:4BEZ, ECO:0007744|PDB:4J4Q,
FT                   ECO:0007744|PDB:4PXF, ECO:0007744|PDB:4X1H,
FT                   ECO:0007744|PDB:5DYS, ECO:0007744|PDB:5EN0,
FT                   ECO:0007744|PDB:5TE3, ECO:0007744|PDB:5TE5"
FT   MUTAGEN         2
FT                   /note="N->C: Stabilized by a disulfide bond and normal
FT                   light absorption; when associated with C-282 and D-15."
FT                   /evidence="ECO:0000269|PubMed:17825322"
FT   MUTAGEN         15
FT                   /note="N->D: Normal light absorption; when associated with
FT                   C-2 and C-282."
FT                   /evidence="ECO:0000269|PubMed:17825322"
FT   MUTAGEN         90
FT                   /note="G->D: Increased thermal stability and decreased
FT                   retinal uptake. Decreases stability of the inactive
FT                   conformation."
FT                   /evidence="ECO:0000269|PubMed:23579341"
FT   MUTAGEN         94
FT                   /note="T->I: Stabilizes the activated conformation and
FT                   hinders hydrolysis of the covalent bond that retains all-
FT                   trans-retinol."
FT                   /evidence="ECO:0000269|PubMed:27458239"
FT   MUTAGEN         113
FT                   /note="E->Q: Causes shift to the activated conformation."
FT                   /evidence="ECO:0000269|PubMed:21389983"
FT   MUTAGEN         257
FT                   /note="M->Y: Causes shift to the activated conformation."
FT                   /evidence="ECO:0000269|PubMed:22198838"
FT   MUTAGEN         282
FT                   /note="D->C: Stabilized by a disulfide bond and normal
FT                   light absorption; when associated with C-2 and D-15."
FT                   /evidence="ECO:0000269|PubMed:17825322"
FT   CONFLICT        281
FT                   /note="S -> F (in Ref. 3; AAA30675)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..5
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   STRAND          10..13
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           15..17
FT                   /evidence="ECO:0007744|PDB:4PXF"
FT   TURN            23..25
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            29..31
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           34..64
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           66..68
FT                   /evidence="ECO:0007744|PDB:4X1H"
FT   HELIX           71..89
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           91..100
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           103..105
FT                   /evidence="ECO:0007744|PDB:1EDS"
FT   HELIX           106..139
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   STRAND          143..145
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           150..168
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           170..172
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            175..177
FT                   /evidence="ECO:0007744|PDB:1EDV"
FT   STRAND          179..181
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            182..185
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   STRAND          186..188
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           192..195
FT                   /evidence="ECO:0007744|PDB:1EDV"
FT   HELIX           196..198
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           200..210
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           213..223
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            224..228
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            229..231
FT                   /evidence="ECO:0007744|PDB:3C9M"
FT   TURN            235..238
FT                   /evidence="ECO:0007744|PDB:3C9L"
FT   STRAND          239..241
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           242..277
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            278..280
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           285..294
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           295..299
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           301..308
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   HELIX           311..321
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   TURN            322..324
FT                   /evidence="ECO:0007744|PDB:4X1H"
FT   TURN            328..330
FT                   /evidence="ECO:0007744|PDB:1U19"
FT   STRAND          332..334
FT                   /evidence="ECO:0007744|PDB:1NZS"
FT   STRAND          336..338
FT                   /evidence="ECO:0007744|PDB:1JFP"
FT   STRAND          339..342
FT                   /evidence="ECO:0007744|PDB:1U19"
SQ   SEQUENCE   348 AA;  39008 MW;  33FDA196803E81F3 CRC64;
     MNGTEGPNFY VPFSNKTGVV RSPFEAPQYY LAEPWQFSML AAYMFLLIML GFPINFLTLY
     VTVQHKKLRT PLNYILLNLA VADLFMVFGG FTTTLYTSLH GYFVFGPTGC NLEGFFATLG
     GEIALWSLVV LAIERYVVVC KPMSNFRFGE NHAIMGVAFT WVMALACAAP PLVGWSRYIP
     EGMQCSCGID YYTPHEETNN ESFVIYMFVV HFIIPLIVIF FCYGQLVFTV KEAAAQQQES
     ATTQKAEKEV TRMVIIMVIA FLICWLPYAG VAFYIFTHQG SDFGPIFMTI PAFFAKTSAV
     YNPVIYIMMN KQFRNCMVTT LCCGKNPLGD DEASTTVSKT ETSQVAPA
//